Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Crystallization Process Control – V 2.0

Posted on By

API Manufacturing: SOP for Crystallization Process Control – V 2.0

Standard Operating Procedure for Crystallization Process Control in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/061/2025
Supersedes SOP/API/061/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standard and validated procedure for carrying out crystallization in API manufacturing, ensuring consistent particle size, purity, and yield by controlling key process parameters.

2. Scope

This SOP applies to all crystallization operations of active pharmaceutical ingredients in production reactors and crystallizers, covering batch and continuous processes within the API manufacturing facility.

3. Responsibilities

  • Production Operators: Follow crystallization process as per the batch record and control parameters.
  • Production Supervisor: Monitor the operation, ensure adherence to parameters, and document process deviations.
  • QA Department: Review records and verify compliance with GMP standards.
  • QC Department: Perform sampling and testing for crystallization endpoints.
See also  API Manufacturing: SOP for Weighing of Raw Materials Under LAF - V 2.0

4. Accountability

The Production Head is accountable for proper execution and documentation of crystallization activities. The QA Head is responsible for ensuring process compliance.

5. Procedure

5.1 Pre-Crystallization Checks

  1. Ensure reactor is cleaned and line clearance is completed.
  2. Verify availability and calibration status of:
    • Temperature probes
    • pH meters
    • Agitators
  3. Ensure all raw materials and solvents are issued as per BMR.

5.2 Crystallization Process Execution

  1. Charge the solution/slurry into the reactor as per approved batch instructions.
  2. Initiate stirring and maintain the required agitation speed (e.g., 100–200 RPM).
  3. Set temperature as per process requirement (e.g., cool from 60°C to 5°C at controlled rate).
  4. Add anti-solvent or seed material, if specified, slowly under continuous agitation.
  5. Monitor temperature drop rate to avoid sudden precipitation or oiling-out.
  6. Maintain crystallization hold time (e.g., 4–6 hrs) or until endpoint is achieved.
See also  API Manufacturing: SOP for Handling of Exothermic Reactions - V 2.0

5.3 Monitoring and Control

  1. Monitor and record:
    • Temperature every 15 minutes
    • Agitation RPM every hour
    • Visual observation of crystal formation
  2. Collect in-process samples for:
    • Microscopic observation (crystal habit)
    • pH and solvent content
    • TLC (if applicable) to confirm completion
  3. Record all data in the “Crystallization Monitoring Log” (Annexure-1).

5.4 Post-Crystallization

  1. Allow slurry to settle (if required) before filtration or centrifugation.
  2. Transfer to next process step (filtration/drying) as per batch plan.
  3. Perform reactor cleaning as per cleaning SOP and document it.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • RPM: Revolutions Per Minute
  • TLC: Thin Layer Chromatography
  • QC: Quality Control
  • QA: Quality Assurance
See also  API Manufacturing: SOP for Disposal of Rejected or Contaminated Materials - V 2.0

7. Documents

  1. Crystallization Monitoring Log (Annexure-1)
  2. Batch Manufacturing Record
  3. Cleaning Record for Equipment

8. References

  • ICH Q8 – Pharmaceutical Development
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Internal Process Validation Protocols

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Crystallization Monitoring Log

Date Batch No. Time Temperature (°C) RPM Crystal Observation Sample Collected
13/04/2025 CRY-20250413 09:15 30 120 Cloudy Appearance Yes

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Process Implementation QA Head
13/04/2025 2.0 Added Detailed Sampling and Observation Steps Process Optimization QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Exit Examination of Volunteers – V 2.0
Next Post: Biosimilars: SOP for Cryopreservation of Cell Banks – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version